News Conference News ESC Heart Failure 2022 Dapagliflozin Boosts Health Status Across LVEF Range Shelley Wood May 23, 2022
News Daily News Good News and Bad for High-Intensity Statin Use in ASCVD Michael O'Riordan May 05, 2022
News Daily News High-Risk Subgroups Derive Kidney Protection from Rosuvastatin Caitlin E. Cox October 11, 2013